目的:对比观察眼内容除去术后生物陶瓷义眼台(法国FCI公司)及羟基磷灰石义眼台(美国IOI公司)植入的临床效果。方法:需行眼内容除去义眼台植入的患者73例73眼,随机分为A,B两组,A组35眼,B组38眼,两组患者均行眼内容除去I期义眼台植入术。A组植入生物陶瓷义眼台,B组植入羟基磷灰石义眼台。结果:术后随访6～15mo,A,B两组患者均未见义眼台暴露、移位及眶内感染,配戴义眼壳后外观满意,活动度佳。结论:眼内容除去后植入生物陶瓷义眼台安全有效,生物陶瓷义眼台是另一种可选择的眶内植入物。

·AIM:To compare the clinical effect of intraorbital implantation of bioceramic spheres and hydroxyapatite spheres after evisceration.·METHODS:Seventy-three eyes of 73 patients were included in this study.Patients were randomly assigned to A,B groups.Thirty-five eyes were included in A group and 38 eyes in B group,respectively.After evisceration,patients in A group received the bioceramic implant and patients in B group received the hydroxyapatite implant.·RESULTS:Patients were followed-up for 6-15 months.There were no complications of implant extrusion,exposure,infection,or migration for patients in both groups.All patients in both groups had a good cosmetic result after final prosthetic fitting.Prosthetic motility was good in all patients.·CONCLUSION:Bioceramic is a safe and effective material of orbital implant for correction of anophthalmos after evisceration.The bioceramic implant is an alternative to the hydroxyapatite implant.·

R779.64